Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | TGM2 | P21980 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | MIF | P14174 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4493048 | 1.00 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2NPC1POLBRAB9A | |
| SCHEMBL2137493 | 0.87 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2NPC1POLBRAB9A | |
| SCHEMBL1557396 | 0.84 | TGM2 (0.54) | ALDH1A1SMN1; SMN2NPC1POLBRAB9A | |
| SCHEMBL483306 | 0.83 | TGM2 (0.56) | ALDH1A1SMN1; SMN2NPC1POLBRAB9A | |
| SCHEMBL16069010 | 0.81 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2NPC1POLBRAB9A | |
| SCHEMBL19279411 | 0.81 | HCAR2 (0.60) | ALDH1A1SMN1; SMN2NPC1POLBRAB9A | |
| SCHEMBL16061893 | 0.81 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2NPC1POLBRAB9A | |
| SCHEMBL16061894 | 0.81 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2NPC1POLBRAB9A | |
| SCHEMBL8775648 | 0.78 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2NPC1POLBRAB9A | |
| SCHEMBL5242238 | 0.77 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2NPC1POLBRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260016750-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-01-15 | — | — | US | disclosed |
| EP-2546257-B1 | BISPHOSPHATE COMPOUND AND ASYMMETRIC REACTION USING SAME | UNIV TOHOKU NAT UNIV CORP (JP) | 2014-08-27 | — | — | EP | disclosed |
| US-8420847-B2 | Bis-phosphate compound and asymmetric reaction using the same | NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) | 2013-04-16 | — | — | US | disclosed |
| US-8420847-B2 | Bis-phosphate compound and asymmetric reaction using the same | NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) | 2013-04-16 | — | — | US | disclosed |
| US-8420847-B2 | Bis-phosphate compound and asymmetric reaction using the same | NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) | 2013-04-16 | — | — | US | disclosed |
| EP-2546257-A1 | BISPHOSPHATE COMPOUND AND ASYMMETRIC REACTION USING SAME | National University Corporation Tohoku University (JP) | 2013-01-16 | — | — | EP | disclosed |
| US-20120330038-A1 | BIS-PHOSPHATE COMPOUND AND ASYMMETRIC REACTION USING THE SAME | API CORPORATION (JP) | 2012-12-27 | — | — | US | disclosed |
| US-20120330038-A1 | BIS-PHOSPHATE COMPOUND AND ASYMMETRIC REACTION USING THE SAME | API CORPORATION (JP) | 2012-12-27 | — | — | US | disclosed |
| US-20120330038-A1 | BIS-PHOSPHATE COMPOUND AND ASYMMETRIC REACTION USING THE SAME | API CORPORATION (JP) | 2012-12-27 | — | — | US | disclosed |
| US-7592463-B2 | An imidazolidinone compounds is used in reaction as catalyst to lower the energy level of the lowest unoccupied molecular orbital | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2009-09-22 | — | — | US | disclosed |
| US-7592463-B2 | An imidazolidinone compounds is used in reaction as catalyst to lower the energy level of the lowest unoccupied molecular orbital | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2009-09-22 | — | — | US | disclosed |
| EP-1461320-B1 | ENANTIOSELECTIVE TRANSFORMATION OF ALFA,BETA-UNSATURATED KETONES USING CHIRAL ORGANIC CATALYSTS | CALIFORNIA INST OF TECHN (US) | 2008-04-09 | — | — | EP | disclosed |
| EP-1461320-B1 | ENANTIOSELECTIVE TRANSFORMATION OF ALFA,BETA-UNSATURATED KETONES USING CHIRAL ORGANIC CATALYSTS | CALIFORNIA INST OF TECHN (US) | 2008-04-09 | — | — | EP | disclosed |
| EP-1461320-A4 | ENANTIOSELECTIVE TRANSFORMATION OF ALFA,BETA-UNSATURATED KETONES USING CHIRAL ORGANIC CATALYSTS | CALIFORNIA INST OF TECHN (US) | 2004-12-08 | — | — | EP | disclosed |
| EP-1461320-A2 | ENANTIOSELECTIVE TRANSFORMATION OF ALFA,BETA-UNSATURATED KETONES USING CHIRAL ORGANIC CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2004-09-29 | — | — | EP | disclosed |
| US-20030220507-A1 | Enantioselective transformation of alpha,beta-unsaturated ketones using chiral organic catalysts | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2003-11-27 | — | — | US | disclosed |
| WO-2003047740-A2 | ENANTIOSELECTIVE TRANSFORMATION OF α,β-UNSATURATED KETONES USING CHIRAL ORGANIC CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2003-06-12 | — | — | WO | disclosed |
| US-6140531-A | HEATING 2-ALKENYL AZIDE IN SOLVENT | PPG INDUSTRIES OHIO, INC. (US) | 2000-10-31 | — | — | US | disclosed |
| US-5387704-A | Preparation of anthraquinones | BASF AKTIENGESELLSCHAFT (DE) | 1995-02-07 | — | — | US | disclosed |
| EP-0516861-A1 | PYRIDONECARBOXYLIC ACID DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1992-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220507-A1 | Enantioselective transformation of alpha,beta-unsaturated ketones using chiral organic catalysts | HACL2, EBP, MED1 | ALDH1A1 8/4885SMN1; SMN2 2844/4885NPC1 3226/4885 |
| US-20260016750-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | C1S, CCNA1, CCNT1 | ALDH1A1 639/4885SMN1; SMN2 2948/4885NPC1 2119/4885 |
| US-20120330038-A1 | BIS-PHOSPHATE COMPOUND AND ASYMMETRIC REACTION USING THE SAME | AASDHPPT, ALDH7A1, ATIC | ALDH1A1 342/4885SMN1; SMN2 4544/4885NPC1 4782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.